S. Bhatia

1.1k total citations
15 papers, 781 citations indexed

About

S. Bhatia is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Bhatia has authored 15 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Bhatia's work include Pancreatic and Hepatic Oncology Research (7 papers), Colorectal and Anal Carcinomas (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). S. Bhatia is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Colorectal and Anal Carcinomas (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). S. Bhatia collaborates with scholars based in United States, Australia and Belgium. S. Bhatia's co-authors include Robert C. Miller, Michael G. Haddock, John H. Donohue, David M. Nagorney, Leonard L. Gunderson, Sunil Krishnan, Nora A. Janjan, Christopher H. Crane, Prajnan Das and Marc E. Delclos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

S. Bhatia

15 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Bhatia United States 9 581 564 379 125 72 15 781
Iwao Ozawa Japan 12 313 0.5× 525 0.9× 289 0.8× 178 1.4× 95 1.3× 49 641
Tsuneshi Fujii Japan 13 871 1.5× 648 1.1× 532 1.4× 124 1.0× 31 0.4× 28 970
Masatsugu Nakajima Japan 12 604 1.0× 503 0.9× 394 1.0× 102 0.8× 68 0.9× 54 839
Noriaki Futakawa Japan 13 564 1.0× 668 1.2× 267 0.7× 139 1.1× 53 0.7× 33 797
Patrick B. White United States 9 481 0.8× 518 0.9× 155 0.4× 176 1.4× 40 0.6× 10 656
Hideki Kamada Japan 17 471 0.8× 522 0.9× 378 1.0× 106 0.8× 139 1.9× 56 815
Tetsuichiro Muto Japan 7 376 0.6× 482 0.9× 192 0.5× 106 0.8× 33 0.5× 8 557
Yoshifumi Arisaka Japan 14 546 0.9× 402 0.7× 296 0.8× 147 1.2× 29 0.4× 48 759
John Chappo United States 11 769 1.3× 585 1.0× 751 2.0× 87 0.7× 23 0.3× 18 957
Masayuki Akita Japan 15 480 0.8× 362 0.6× 203 0.5× 86 0.7× 68 0.9× 44 629

Countries citing papers authored by S. Bhatia

Since Specialization
Citations

This map shows the geographic impact of S. Bhatia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bhatia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bhatia more than expected).

Fields of papers citing papers by S. Bhatia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bhatia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bhatia. The network helps show where S. Bhatia may publish in the future.

Co-authorship network of co-authors of S. Bhatia

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bhatia. A scholar is included among the top collaborators of S. Bhatia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bhatia. S. Bhatia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bhatia, S., Ann W. Silk, Ren‐Chin Wu, et al.. (2024). Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress. SHILAP Revista de lepidopterología. 2. 100240–100240. 1 indexed citations
2.
Sio, Terence T., Michael C. Stauder, S. Bhatia, et al.. (2014). Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer. American Journal of Clinical Oncology. 39(5). 448–452. 6 indexed citations
3.
Özşahin, Mahmut, et al.. (2012). The Rare Cancer Network: Achievements from 1993 to 2012. Rare Tumors. 4(3). 110–114. 16 indexed citations
4.
Narang, Amol, Robert C. Miller, Charles C. Hsu, et al.. (2011). Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study. Radiation Oncology. 6(1). 126–126. 78 indexed citations
5.
Bhatia, S., Leszek Miszczyk, Martine Roelandts, et al.. (2011). Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network study. SHILAP Revista de lepidopterología. 3(4). 150–152. 23 indexed citations
6.
Gold, Douglas G., Robert C. Miller, Michael G. Haddock, et al.. (2009). Adjuvant Therapy for Gallbladder Carcinoma: The Mayo Clinic Experience. International Journal of Radiation Oncology*Biology*Physics. 75(1). 150–155. 105 indexed citations
7.
Krishnan, Sunil, Vishal Rana, Douglas B. Evans, et al.. (2008). Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of Vater. International Journal of Radiation Oncology*Biology*Physics. 70(3). 735–743. 59 indexed citations
8.
Herman, Joseph M., Chiun Hsu, Jianping Zhou, et al.. (2008). Benefit of Adjuvant Chemoradiation Therapy for Ampullary Adenocarcinoma: The Johns Hopkins Hospital - Mayo Clinic Collaborative Study. International Journal of Radiation Oncology*Biology*Physics. 72(1). S126–S126. 1 indexed citations
9.
Corsini, Michele M., Robert C. Miller, Michael G. Haddock, et al.. (2008). Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005). Journal of Clinical Oncology. 26(21). 3511–3516. 195 indexed citations
10.
Das, Prajnan, S. Bhatia, Cathy Eng, et al.. (2007). Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer. International Journal of Radiation Oncology*Biology*Physics. 68(3). 794–800. 134 indexed citations
11.
Corsini, Michele M., Robert C. Miller, Michael G. Haddock, et al.. (2007). Adjuvant Radiation and Chemotherapy for Pancreatic Adenocarcinoma: The Mayo Clinic Experience. International Journal of Radiation Oncology*Biology*Physics. 69(3). S79–S79. 1 indexed citations
12.
Bhatia, S., Robert C. Miller, Michael G. Haddock, John H. Donohue, & Sunil Krishnan. (2006). Adjuvant therapy for ampullary carcinomas: The Mayo Clinic experience. International Journal of Radiation Oncology*Biology*Physics. 66(2). 514–519. 89 indexed citations
13.
Das, Prajnan, Edward H. Lin, S. Bhatia, et al.. (2006). Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis. International Journal of Radiation Oncology*Biology*Physics. 66(5). 1378–1383. 61 indexed citations
14.
Bhatia, S., et al.. (2006). Neck extensor muscle weakness (Dropped head syndrome) following radiotherapy. 40(1). 7 indexed citations
15.
Das, Prajnan, E. Lin, S. Bhatia, et al.. (2005). Neoadjuvant Chemoradiation with Capecitabine Versus Infusional 5-fluorouracil (5-FU) for Locally Advanced Rectal Cancer: A Matched Pair Analysis. International Journal of Radiation Oncology*Biology*Physics. 63. S164–S164. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026